• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOTRONIK SE & CO. KG ENITRA 8 DR-T; PACEMAKER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOTRONIK SE & CO. KG ENITRA 8 DR-T; PACEMAKER Back to Search Results
Model Number 407147
Device Problems Intermittent Capture (1080); Pacing Intermittently (1443)
Patient Problem Syncope/Fainting (4411)
Event Date 06/24/2023
Event Type  malfunction  
Event Description
Patient admitted to hospital with syncope.12 lead ecg showed pauses.Then pacemaker was interrogated.It was noted that there was no high output/backup pacing with loss of capture on ventricular lead with capture control on.Capture control in ventricle was switched off, with fixed 3v at 1.0ms output.Patient is requested to return in 1 month for further analysis.Patient was monitored for 1 hour and then discharged.Device remains implanted.Should additional information be received, this file will be updated.
 
Manufacturer Narrative
The pacemaker was not returned for analysis.The analysis is therefore based on the returned device data, as well as the inspection of the quality documents associated with the manufacture of this particular device.The manufacturing process for pacemaker was re-investigated and all production steps were performed accordingly.There was no sign of any inconsistency during the manufacturing process which may be related to the clinical observation.Available device data have been thoroughly analyzed, in particular the ecg of (b)(6) 2023, at 03:33 pm which documented ineffective right ventricular stimulation without backup stimulation.Based on all data available for analysis the exact root cause for the clinical observation could not be conclusively determined.However, it cannot be excluded that the clinical observation resulted from polarization artifacts of the ventricular lead.It was reported that the pacemaker was reprogrammed to capture control off with a fixed ventricular amplitude of 3.0 v at 1.0 ms.In summary, the device was not returned for analysis.The review of the quality documents confirmed a regular device manufacturing.The available data revealed that polarization artifacts from the ventricular lead most likely led to the clinical observation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENITRA 8 DR-T
Type of Device
PACEMAKER
Manufacturer (Section D)
BIOTRONIK SE & CO. KG
woermannkehre 1
berlin 12359
Manufacturer Contact
6024 jean road
lake oswego, OR 97035
8772459800
MDR Report Key17273162
MDR Text Key318598264
Report Number1028232-2023-03296
Device Sequence Number1
Product Code NVZ
Combination Product (y/n)N
PMA/PMN Number
P950037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 08/02/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/31/2024
Device Model Number407147
Device Catalogue NumberSEE MODEL NO.
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/30/2023
Initial Date FDA Received07/06/2023
Supplement Dates Manufacturer Received08/02/2023
Supplement Dates FDA Received08/02/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/08/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
-
-